Pharmaceutical Executive August 19, 2025
Key Takeaways
- Whole genome sequencing market is projected to grow from $3 billion in 2025 to $6.1 billion by 2030, with a 15.1% CAGR.
- Growth drivers include advancements in cancer genomics, rare disease research, and decreasing sequencing costs.
- WGS is increasingly used in personalized medicine, diagnostics, and drug development, reducing reliance on single-gene tests.
- North America is expected to hold the largest market share, with consumables as the dominant product type through 2030.
Whole genome sequencing market is projected to grow significantly, driven by advancements in technology and personalized medicine, reaching $6.1 billion by 2030.
BCC Research revealed results from its most recent study “Whole Genome Sequencing: Global Markets,” showing expectations for growth from $3 billion in 2025...
Today's Sponsors
Today's Sponsor